Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities
In accordance with its long-term incentive program ("LTIP") Ambu A/S has allocated performance share units (PSUs) to members of the Executive...
Staff
Launch of Long-Term Incentive Plan
In accordance with the Remuneration Policy approved at the annual general meeting on 17 December 2019, Ambu A/S has today...
Biogen and Eisai Announce FDA’s 3-Month Extension of Review Period for the Biologics License Application for Aducanumab
The new Prescription Drug User Fee Act (PDUFA) action date set by the FDA is June 7, 2021 CAMBRIDGE, Mass....
MediPharm Labs Appoints New Chief Financial Officer
TORONTO, Jan. 29, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”)...
OncXerna Therapeutics Appoints Colleen Mockbee as Chief Development Officer and Senior Vice President of Regulatory Affairs
WALTHAM, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) -- OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-based biomarker...
Life Line Screening accelerates its clinical research transformation by appointing Matthew Maxwell as Chief of Clinical Research Strategy.
Mr. Maxwell will be responsible for unlocking Life Line Screening’s distinctive ability to connect motivated patients to compelling clinical research...
Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer
Commercial Launch of Libmeldy™ in Europe On-Track for 1H 2021BOSTON and LONDON, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a...
AIM ImmunoTech Enters into Agreement for Proposed Intranasal Safety Study of Ampligen
AIM is Working to Develop an Effective COVID-19 Intranasal TherapyOCALA, Fla., Jan. 29, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc....
Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board
Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board Development of lead asset SPVN06 to further benefit from high-level Clinical...
OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test
This is the Eighth EUA to Include a Self-Collection Device from DNA GenotekBETHLEHEM, Pa., Jan. 29, 2021 (GLOBE NEWSWIRE) --...
Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board
Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board Development of lead asset SPVN06 to further benefit from high-level Clinical...
Nicox Amends Bond Financing Agreement with Kreos to Provide Financial Flexibility in 2021
Press ReleaseNicox Amends Bond Financing Agreement with Kreos to Provide Financial Flexibility in 2021 January 29, 2021 – release at...
January 30th to Mark the Second Annual World NTD Day
World NTD Day A commitment to future generations. Three young girls in Sankura, Ethiopia, an area impacted by NTDs. Photo...
Outlook Therapeutics Increases Previously Announced Bought Deal Offering of Common Stock to $35.0 Million
MONMOUTH JUNCTION, N.J., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a late clinical-stage biopharmaceutical company working to...
Disclosure of received notification of BNP Paribas Asset Management SA
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 29 January 2021 Disclosure of received notification of BNP Paribas Asset Management SA Pursuant to...
Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company...
El Paso TX Diabetic Foot Ulcers Podiatric Wound Care Specialist Services Launch
El Paso, Texas, based podiatric care specialist Dr Rebecca Rosado of Foot and Ankle Partners of El Paso providing a...
Evelo Biosciences Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing a...
Oncology Pharma Announces the Appointment Of New Chief Financial Officer
San Francisco, CA, Jan. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma Inc. (OTC: ONPH) is pleased to announce...
Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2020
NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...